Off-label drug in the newborn
The lack of specific drugs and labelling recommendations for the neonatal population is a long-standing problem throughout the world. With the introduction of the Paediatric Regulation in 2007, in Europe tangible steps have been made to increase clinical research in children, but only a limited numb...
Main Author: | Laura Cuzzolin |
---|---|
Format: | Article |
Language: | English |
Published: |
Hygeia Press di Corridori Marinella
2014-10-01
|
Series: | Journal of Pediatric and Neonatal Individualized Medicine |
Subjects: | |
Online Access: | https://www.jpnim.com/index.php/jpnim/article/view/183 |
Similar Items
-
Antibiotics and antifungals in VLBW infants
by: Laura Cuzzolin
Published: (2015-10-01) -
Pattern and extent of off-label and unlicensed drug use in neonatal intensive care units in Iran
by: Leila Kouti, et al.
Published: (2019-01-01) -
Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China.
by: Weilan Wang, et al.
Published: (2013-05-01) -
Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China
by: Weilan Wang, et al.
Published: (2013-05-01) -
Evaluation of Knowledge, Attitudes and Experience of off-label Drug Prescribing Practice among Physicians in Baghdad City Hospitals
by: Aysha M. Shanshal, et al.
Published: (2019-12-01)